A new Nature Reviews Disease Primers article distills essential clinical insights on atopic dermatitis management. First, clinicians must recognize the variable global disease burden—approximately 1 in 10 people worldwide are affected, with prevalence concentrated in developed nations at 10-15%. Second, understanding the underlying pathophysiology is crucial: atopic dermatitis results from complex interplay between genetic factors, impaired skin barrier function, and dysregulated immune responses. Each of these mechanisms is now targetable through distinct therapeutic approaches.
Third, modern treatment strategies have evolved substantially. Comprehensive management now combines foundational barrier restoration with emollients, psychological support addressing quality-of-life impacts, and targeted biologic therapies for moderate-to-severe cases. Early diagnosis paired with this stratified, multidisciplinary approach significantly improves patient outcomes across sleep, productivity, and psychological wellbeing domains. Healthcare providers should adopt precision medicine frameworks to optimize individual treatment plans and enhance long-term disease control.
Read the full article on GMJ Newsroom.
Was this article helpful?
